Freeline Therapeutics Holdings plc financial data

Location
Sycamore House, Gunnels Wood Road, Stevenage, Hertfordshire, United Kingdom
Fiscal year end
December 31
Latest financial report
6-K - Q1 2023 - May 30, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 235 % -47.2%
Debt-to-equity 55.1 % +8.19%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 65.4M shares +0.61%
Weighted Average Number of Shares Outstanding, Basic 65.1M shares +52.7%
Weighted Average Number of Shares Outstanding, Diluted 65.8M shares +54.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 10.9M USD -45.4%
General and Administrative Expense 8.05M USD -2.08%
Operating Income (Loss) -20.1M USD +28.7%
Nonoperating Income (Expense) 21.4M USD +1366%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.33M USD
Income Tax Expense (Benefit) 162K USD +636%
Net Income (Loss) Attributable to Parent 1.17M USD
Earnings Per Share, Basic 0.02 USD/shares
Earnings Per Share, Diluted 0.02 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 29.5M USD -55.3%
Other Assets, Current 953K USD -23.6%
Assets, Current 34M USD -54.1%
Property, Plant and Equipment, Net 8.63M USD -20%
Operating Lease, Right-of-Use Asset 3.93M USD -66.5%
Other Assets, Noncurrent 2.67M USD -23.3%
Assets 49.2M USD -50.8%
Accounts Payable, Current 7.78M USD -21.9%
Employee-related Liabilities, Current 2.74M USD -31.3%
Liabilities, Current 17.5M USD -22%
Operating Lease, Liability, Noncurrent 1.7M USD -81.2%
Liabilities 19.2M USD -39.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.57M USD +82.3%
Retained Earnings (Accumulated Deficit) -472M USD -11.8%
Stockholders' Equity Attributable to Parent 30M USD -56.2%
Liabilities and Equity 49.2M USD -50.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -18.4M USD +30.6%
Net Cash Provided by (Used in) Investing Activities 23.8M USD
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 65.4M shares +0.61%
Common Stock, Par or Stated Value Per Share 0 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6.51M USD
Operating Lease, Liability 3.99M USD -66.7%
Payments to Acquire Property, Plant, and Equipment 392K USD -25.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 2.44M USD
Lessee, Operating Lease, Liability, to be Paid 4.34M USD -74.2%
Property, Plant and Equipment, Gross 14.7M USD -14%
Operating Lease, Liability, Current 2.29M USD -20.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 675K USD -74.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.94M USD -45.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure +54.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 383K USD -92.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 654K USD -54.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 326K USD -73.5%
Operating Lease, Payments 765K USD -75.8%
Additional Paid in Capital 504M USD +0.82%
Depreciation, Depletion and Amortization 320K USD -40.9%
Share-based Payment Arrangement, Expense 973K USD -29.3%